1. Academic Validation
  2. Antibiotic Korormicin A Kills Bacteria by Producing Reactive Oxygen Species

Antibiotic Korormicin A Kills Bacteria by Producing Reactive Oxygen Species

  • J Bacteriol. 2019 May 8;201(11):e00718-18. doi: 10.1128/JB.00718-18.
Adam Maynard 1 2 Nicole L Butler # 3 2 Takeshi Ito # 2 Adilson José da Silva 2 4 5 Masatoshi Murai 6 Tsute Chen 7 8 Mattheos A G Koffas 1 2 4 Hideto Miyoshi 6 Blanca Barquera 9 2
Affiliations

Affiliations

  • 1 Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • 2 Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • 3 Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • 4 Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • 5 Chemical Engineering Department, Federal University of Sao Carlos, Sao Paulo, Brazil.
  • 6 Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
  • 7 The Forsyth Institute, Cambridge, Massachusetts, USA.
  • 8 School of Dental Medicine, Harvard University, Boston, Massachusetts, USA.
  • 9 Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA barqub@rpi.edu.
  • # Contributed equally.
Abstract

Korormicin is an Antibiotic produced by some pseudoalteromonads which selectively kills Gram-negative bacteria that express the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR.) We show that although korormicin is an inhibitor of Na+-NQR, the Antibiotic action is not a direct result of inhibiting Enzyme activity. Instead, perturbation of electron transfer inside the Enzyme promotes a reaction between O2 and one or more redox cofactors in the Enzyme (likely the flavin adenine dinucleotide [FAD] and 2Fe-2S center), leading to the production of Reactive Oxygen Species (ROS). All Pseudoalteromonas contain the nqr operon in their genomes, including Pseudoalteromonas strain J010, which produces korormicin. We present activity data indicating that this strain expresses an active Na+-NQR and that this Enzyme is not susceptible to korormicin inhibition. On the basis of our DNA sequence data, we show that the Na+-NQR of Pseudoalteromonas J010 carries an amino acid substitution (NqrB-G141A; Vibrio cholerae numbering) that in Other Na+-NQRs confers resistance against korormicin. This is likely the reason that a functional Na+-NQR is able to exist in a bacterium that produces a compound that typically inhibits this Enzyme and causes cell death. Korormicin is an effective Antibiotic against such pathogens as Vibrio cholerae, Aliivibrio fischeri, and Pseudomonas aeruginosa but has no effect on Bacteroides fragilis and Bacteroides thetaiotaomicron, Microorganisms that are important members of the human intestinal microflora.IMPORTANCE As multidrug Antibiotic resistance in pathogenic bacteria continues to rise, there is a critical need for novel antimicrobial agents. An essential requirement for a useful Antibiotic is that it selectively targets bacteria without significant effects on the eukaryotic hosts. Korormicin is an excellent candidate in this respect because it targets a unique respiratory Enzyme found only in prokaryotes, the Na+-pumping NADH:quinone oxidoreductase (Na+-NQR). Korormicin is synthesized by some species of the marine bacterium Pseudoalteromonas and is a potent and specific inhibitor of Na+-NQR, an Enzyme that is essential for the survival and proliferation of many Gram-negative human pathogens, including Vibrio cholerae and Pseudomonas aeruginosa, among Others. Here, we identified how korormicin selectively kills these bacteria. The binding of korormicin to Na+-NQR promotes the formation of Reactive Oxygen Species generated by the reaction of the FAD and the 2Fe-2S center cofactors with O2.

Keywords

Na+-NQR; antibiotic; korormicin; reactive oxygen species.

Figures
Products